Search clinical trials for: Narcotics

Total 13573 results

Carilion Clinic

Completed

Narcotic Use After Minor Hand Surgery

Pain, Postoperative | Minor Surgical Procedures | Narcotics Use
University of Arizona

Enrolling by invitation

Pain Management Study

Pain, Postoperative

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2

Substance-Related Disorders | Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1

Substance Abuse, Intravenous | Opioid-Related Disorders | Heroin Dependence

United States
University of California, Los Angeles

Completed

Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Yale University

Completed

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Completed

Effects of Buprenorphine and Naloxone in Opiate Addicts - 4

Substance-Related Disorders | Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Clinical Rescue Protocol - 2

Opioid-Related Disorders

United States
Mundipharma Research Limited

Completed

Bioequivalence and Adhesion Comparison of Buprenorphine Patches

Pain

United Kingdom
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dosing Interval - 5

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase IV - 5

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VI - 7

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Gradual Vs. Rapid Buprenorphine Detoxification - 2

Opioid-Related Disorders

United States
Brigham and Women's Hospital
University of Utah

Not yet recruiting

Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder

Opioid Use Disorder
University Hospital, Clermont-Ferrand

Active, not recruiting

High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid (SEVROP)

High Dosage Buprenorphine

France
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 1

Opioid-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care

Substance Abuse, Intravenous | Opioid-Related Disorders | Heroin Dependence

United States
Mundipharma Research Limited

Terminated

A Study to Characterize the Pharmacokinetics and Tolerability of Buprenorphine Patches in Children With Moderate to Severe Mouth Pain (BUP1501)

Chemotherapy Induced Mucositis | Mouth Pain

Denmark, United Kingdom
National Institute on Drug Abuse (NIDA)

Completed

Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance Protocol - 1

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Multicenter Clinical Trial of Buprenorphine - 3

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate Day Buprenorphine Administration, Phase XI - 16

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dose Alteration Study - 1

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate Day Buprenorphine Administration, Phase IX - 14

Opioid-Related Disorders

United States
Grünenthal GmbH

Terminated

Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID 297307)

Healthy

Germany
Grünenthal GmbH

Terminated

Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID: 855509)

Healthy

Germany
Danish University of Pharmaceutical Sciences

Unknown

Pharmacokinetics and Pharmacodynamics of Buprenorphine in Healthy Volunteers

Healthy Volunteers

Denmark
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification - BBDVI - 19

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase I - 3

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine. Phase V - 6

Opioid-Related Disorders

United States
Aurora Quaye
MaineHealth

Terminated

The Effect of Buprenorphine Continuation for Patients With Opioid Use Disorder

Opioid-use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 2

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 3

Opioid-Related Disorders

United States
Virginia Commonwealth University

Completed

Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal

Drug Overdose | Opioid-use Disorder | Opioid Withdrawal

United States
University of Pittsburgh
National Institutes of Health (NIH); National Center for Research Resources... and other collaborators

Completed

Buprenorphine for Late-Life Treatment Resistant Depression (BUILD)

Depression

United States
National Institute on Drug Abuse (NIDA)
Cincinnati MDRU

Completed

Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Completed

Buprenorphine Maintenance for Opiate Dependence - 6

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Liquid vs. Tablet Buprenorphine - 6

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Mclean Hospital

Completed

Treatment Efficacy for Drug Abuse and AIDS Prevention - 2

Heroin Dependence | Cocaine-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detox With Two Types of Treatment. BBD II - 11

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate-Day Buprenorphine Administration. Phase VIII - 9

Opioid-Related Disorders

United States
Mundipharma Korea Ltd

Completed

An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders (NOBLE)

Spinal Disorder

Korea, Republic of
National Institute on Drug Abuse (NIDA)

Completed

Study Comparing Liquid and Tablet Buprenorphine Formulations - 5

Heroin Dependence

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 21

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase X - 15

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase XII - 17

Opioid-Related Disorders

United States

Search clinical trials for: Narcotics

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations